January 07, 2015
Authored and Edited by Brian R. Westley
Although plaintiffs seeking a preliminary injunction in Lanham Act cases are not entitled to a presumption of irreparable harm, they can rely on inferences of harm, the Third Circuit has ruled.
In Groupe SEB USA, Inc. v. Euro-Pro Operating LLC, a manufacturer of steam irons sued a competitor for false advertising under Section 43(a) of the Lanham Act, alleging that the competitor’s advertising wrongly stated that its product delivered more steam at half the price. No. 14-cv-2767, 2014 WL 7172253, at *9 (3d Cir. Dec. 17, 2014). Following the district court’s grant of plaintiff’s motion for a preliminary injunction, the defendant appealed, arguing, among other things, that the manufacturer failed to establish a likelihood of irreparable harm.
The Third Circuit noted that under Ferring Pharmaceuticals, Inc. v. Watson Pharmaceuticals, Inc., courts may award preliminary injunctive relief under the Lanham Act only upon a “clear showing” of a likelihood of irreparable harm. 765 F.3d 205 (3d Cir. 2014). That decision relied on eBay, Inc. v. MercExchange, LLC, in which the Supreme Court held that patent plaintiffs are not entitled to a presumption of irreparable injury.
The defendant in Groupe SEB USA argued that the district court erroneously applied a de facto presumption of harm standard. The Third Circuit, however, determined that even if the district court erred, the record still contained sufficient evidence of likely harm to plaintiff’s reputation and goodwill. The plaintiff’s marketing director, for example, testified that defendant’s false advertising would likely harm plaintiff’s “first-rate reputation” among retailers and consumers.
In finding that the plaintiff established a likelihood of irreparable harm, the Third Circuit explained that Ferring “does not bar drawing fair inferences from facts in the record. Indeed, a key lesson from Ferring is that courts considering whether to grant injunctive relief must exercise their equitable discretion in a case-by-case, fact-specific manner.” Id. at *11.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Webinar
June 13, 2024
Webinar
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.